You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin aspart, insulin aspart protamine drug combination 30:70

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Graz (Insulin Aspart, Insulin Aspart 30, Insulin Aspart 70)

Completed
Has Results
  • Type 2 Diabetes
  • Insulin Aspart
  • +2 more
  • Graz, Austria
    Medical University of Graz, Department for Internal Medicine
Jun 9, 2021

Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE (HOE901)
  • +5 more
  • China, China
    CHINA
Apr 21, 2022

Diabetes, Type 1, Diabetes, Type 2 Trial in China (Faster aspart, Insulin aspart, Insulin degludec)

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Faster aspart
  • +2 more
  • Hefei, Anhui, China
  • +34 more
Nov 3, 2022

Diabetes Trial in Chengdu (INS062 injection, Insulin Aspart, HR20014 injection)

Recruiting
  • Diabetes
  • INS062 injection
  • +3 more
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Feb 8, 2023

To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Trial in

Completed
  • To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
  • Glargine and regular insulin versus NPH and regular insulin
  • Lahore, Punjab, Pakistan
    Pediatric endocrine and diabetes section, Pediatric department,
Jan 29, 2023

Hyperkalemia Trial in France (Salbutamol, Insulin Aspart)

Recruiting
  • Hyperkalemia
  • Agen, France
  • +15 more
Feb 4, 2022

Diabetes, Type 1 Trial in Worldwide (insulin icodec, insulin degludec, insulin aspart)

Completed
  • Diabetes Mellitus, Type 1
  • insulin icodec
  • +2 more
  • Concord, California
  • +98 more
Feb 2, 2023

Diabetes, Type 2 Trial in Worldwide (IcoSema, Insulin glargine, insulin aspart)

Recruiting
  • Diabetes Mellitus, Type 2
  • La Jolla, California
  • +100 more
Mar 24, 2022

Diabetes, Diabetes, Type 1 Trial in Worldwide (Insulin degludec, Insulin Aspart, Insulin detemir)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Insulin degludec
  • +2 more
  • Caba, Argentina
  • +70 more
Mar 29, 2022

Diabetes Trial (Insulin Degludec and Insulin Aspart)

Not yet recruiting
  • Diabetes
  • Insulin Degludec and Insulin Aspart
  • (no location specified)
Apr 4, 2023

Type 2 Diabetes Trial in Lexington (NPH/Regular 70/30 mix, insulin aspart protamine/insulin aspart 70/30 mix)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • NPH/Regular 70/30 mix
  • insulin aspart protamine/insulin aspart 70/30 mix
  • Lexington, Kentucky
    VA Medical Center - Lexington 596
Feb 19, 2020

Diabetes, Type 1 Trial in Manchester (FIASP + closed loop device, Insulin aspart (standard of care insulin) + closed loop

Completed
  • Diabetes Mellitus, Type 1
  • FIASP + closed loop device
  • Insulin aspart (standard of care insulin) + closed loop device
  • Manchester, United Kingdom
    Manchester University Hospitals NHS Foundation Trust
Aug 19, 2022

Diabetes, Type 2 Trial in Graz (AT278, NovoRapid, Humulin R 500 UNT/ML Injectable Solution)

Recruiting
  • Diabetes Mellitus, Type 2
  • Graz, Austria
    Clinical Trials Unit, Medical University of Graz
Mar 3, 2023

Atherosclerosis, Diabetes, Restenosis Trial in Stockholm (Bydureon, Humulin kwickpen, Metformin)

Recruiting
  • Atherosclerosis
  • +2 more
  • Stockholm, Other, Sweden
    Dept of clinical science and education Karolinska Institutet Söd
Aug 31, 2021

Diabetes, Type 2 Trial (Premixed Human Isophane Insulin Suspension + Human Insulin Injection, Premixed Insulin)

Completed
  • Diabetes Mellitus, Type 2
  • Premixed Human Isophane Insulin Suspension + Human Insulin Injection
  • Premixed Insulin
  • (no location specified)
Jan 23, 2021

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin glargine, Insulin aspart)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +2 more
  • Concord, California
  • +82 more
Jul 7, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +3 more
  • Concord, California
  • +166 more
Jan 6, 2022

Type 1 Diabetes Trial in Cambridge (CamAPS FX using faster insulin aspart, CamAPS FX using standard insulin aspart)

Active, not recruiting
  • Type 1 Diabetes Mellitus
  • CamAPS FX using faster insulin aspart
  • CamAPS FX using standard insulin aspart
  • Cambridge, Cambridgeshire, United Kingdom
  • +1 more
Nov 9, 2022

Type 2 Diabetes Trial in China (Insulin Degludec and Insulin Aspart Injection, Insulin Aspart Injection)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Insulin Degludec and Insulin Aspart Injection
  • Insulin Aspart Injection
  • Shijiazhuang, Hebei, China
  • +5 more
Jun 13, 2022

Type1diabetes Trial in New Haven (Aspart insulin)

Recruiting
  • Type1diabetes
  • Aspart insulin
  • New Haven, Connecticut
    Yale University School of Medicine
May 19, 2022

Type 2 Diabetes Trial in Gurgaon (Degludec, Glargine U300)

Completed
  • Type 2 Diabetes
  • Gurgaon, Haryana, India
    Division Of Endocrinology and Diabetes , Medanta The Medicity Ho
Mar 3, 2022

Type 1 Diabetes Trial in Canada, Sweden, United States (MiniMed 780G System)

Recruiting
  • Type 1 Diabetes
  • MiniMed 780G System
  • Little Rock, Arkansas
  • +14 more
Jan 20, 2023

Looking at How NovoMix® Works in People With Type 2 Diabetes in

Withdrawn
  • Diabetes Mellitus, Type 2
  • BIAsp 30
  • Algiers, Algeria
  • +1 more
Jul 17, 2020

Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes Trial in Chicago (NPH Insulin, glargine, Insulin Aspart)

Terminated
Has Results
  • Hyperglycemia Steroid-induced
  • Insulin Resistance, Diabetes
  • NPH Insulin
  • +2 more
  • Chicago, Illinois
    Northwestern University Feinberg School of Medicine
Aug 25, 2020

Diabetes, Type 1 Trial in Graz (NNC0471-0119 A, NNC0471-0119 B, NNC0471-0119 D)

Active, not recruiting
  • Diabetes Mellitus, Type 1
  • NNC0471-0119 A
  • +3 more
  • Graz, Austria
    Novo Nordisk Investigational Site
Aug 15, 2022